Do analysts recommend ICU or AEMD?

SeaStar Medical presently has a consensus target price of $8.00, suggesting a potential upside of 132.56%. Given SeaStar Medical's stronger consensus rating and higher probable upside, research analysts clearly believe SeaStar Medical is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media favor ICU or AEMD?

In the previous week, SeaStar Medical and SeaStar Medical both had 3 articles in the media. Aethlon Medical's average media sentiment score of 0.98 beat SeaStar Medical's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SeaStar Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend FEMY or AEMD?

Femasys currently has a consensus target price of $106.67, indicating a potential upside of 2,560.02%. Given Femasys' stronger consensus rating and higher probable upside, analysts plainly believe Femasys is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is FEMY or AEMD more profitable?

Aethlon Medical has a net margin of 0.00% compared to Femasys' net margin of -521.97%. Aethlon Medical's return on equity of -137.73% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets Femasys -521.97% -258.08% -73.72% Aethlon Medical N/A -137.73% -105.87%

Do analysts rate MBAI or AEMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has better earnings & valuation, MBAI or AEMD?

Check-Cap is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Check-Cap N/A N/A $4.14M -$2.77 N/A Aethlon Medical N/A N/A -$7.15M -$14.69 N/A

Is MBAI or AEMD more profitable?

Check-Cap's return on equity of 0.00% beat Aethlon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Check-Cap N/A N/A N/A Aethlon Medical N/A -137.73% -105.87%

Does the media favor MBAI or AEMD?

In the previous week, Aethlon Medical had 2 more articles in the media than Check-Cap. MarketBeat recorded 3 mentions for Aethlon Medical and 1 mentions for Check-Cap. Aethlon Medical's average media sentiment score of 0.98 beat Check-Cap's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate AEMD or SURG?

SurgePays has a consensus price target of $3.50, suggesting a potential upside of 782.50%. Given SurgePays' stronger consensus rating and higher possible upside, analysts plainly believe SurgePays is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 SurgePays 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67

Is AEMD or SURG more profitable?

Aethlon Medical has a net margin of 0.00% compared to SurgePays' net margin of -64.91%. Aethlon Medical's return on equity of -137.73% beat SurgePays' return on equity. Company Net Margins Return on Equity Return on Assets Aethlon Medical N/A -137.73% -105.87% SurgePays -64.91% -967.32% -310.16%

Does the media refer more to AEMD or SURG?

In the previous week, Aethlon Medical had 1 more articles in the media than SurgePays. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for SurgePays. SurgePays' average media sentiment score of 1.15 beat Aethlon Medical's score of 0.98 indicating that SurgePays is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SurgePays 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend AEMD or SINT?

Sintx Technologies has a consensus price target of $9.33, indicating a potential upside of 386.11%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Sintx Technologies 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Does the media favor AEMD or SINT?

In the previous week, Aethlon Medical had 2 more articles in the media than Sintx Technologies. MarketBeat recorded 3 mentions for Aethlon Medical and 1 mentions for Sintx Technologies. Aethlon Medical's average media sentiment score of 0.98 beat Sintx Technologies' score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Aethlon Medical (AEMD) Competitors

$1.36 -0.02 (-1.45%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$1.43 +0.07 (+5.07%)

As of 07:17 AM Eastern

Compare

AEMD vs. ICU, FEMY, MBAI, SURG, and SINT

Should you buy Aethlon Medical stock or one of its competitors? MarketBeat compares Aethlon Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aethlon Medical include SeaStar Medical (ICU), Femasys (FEMY), Check-Cap (MBAI), SurgePays (SURG), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry.

How does Aethlon Medical compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

Aethlon Medical has a net margin of 0.00% compared to SeaStar Medical's net margin of -828.62%. Aethlon Medical's return on equity of -137.73% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-828.62%	-146.29%	-96.48%
Aethlon Medical	N/A	-137.73%	-105.87%

SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.49, indicating that its share price is 49% more volatile than the broader market.

In the previous week, SeaStar Medical and SeaStar Medical both had 3 articles in the media. Aethlon Medical's average media sentiment score of 0.98 beat SeaStar Medical's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SeaStar Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 0.7% of Aethlon Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

SeaStar Medical presently has a consensus target price of $8.00, suggesting a potential upside of 132.56%. Given SeaStar Medical's stronger consensus rating and higher probable upside, research analysts clearly believe SeaStar Medical is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Aethlon Medical has lower revenue, but higher earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	11.19	-$12.15M	-$4.80	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A

Summary

Aethlon Medical beats SeaStar Medical on 8 of the 14 factors compared between the two stocks.

How does Aethlon Medical compare to Femasys?

Femasys (NASDAQ:FEMY) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

Aethlon Medical has a net margin of 0.00% compared to Femasys' net margin of -521.97%. Aethlon Medical's return on equity of -137.73% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-521.97%	-258.08%	-73.72%
Aethlon Medical	N/A	-137.73%	-105.87%

In the previous week, Aethlon Medical had 3 more articles in the media than Femasys. MarketBeat recorded 3 mentions for Aethlon Medical and 0 mentions for Femasys. Aethlon Medical's average media sentiment score of 0.98 beat Femasys' score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Femasys	Neutral
Aethlon Medical	Positive

Aethlon Medical has lower revenue, but higher earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	5.29	-$18.63M	-$5.40	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A

Femasys currently has a consensus target price of $106.67, indicating a potential upside of 2,560.02%. Given Femasys' stronger consensus rating and higher probable upside, analysts plainly believe Femasys is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Femasys has a beta of -2.23, indicating that its stock price is 323% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.49, indicating that its stock price is 49% more volatile than the broader market.

65.3% of Femasys shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 7.8% of Femasys shares are owned by company insiders. Comparatively, 0.7% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Femasys beats Aethlon Medical on 8 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Check-Cap?

Check-Cap (NASDAQ:MBAI) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Check-Cap's return on equity of 0.00% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Check-Cap	N/A	N/A	N/A
Aethlon Medical	N/A	-137.73%	-105.87%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Aethlon Medical had 2 more articles in the media than Check-Cap. MarketBeat recorded 3 mentions for Aethlon Medical and 1 mentions for Check-Cap. Aethlon Medical's average media sentiment score of 0.98 beat Check-Cap's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Check-Cap	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Check-Cap has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market.

Check-Cap is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Check-Cap	N/A	N/A	$4.14M	-$2.77	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A

1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Comparatively, 0.7% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Aethlon Medical beats Check-Cap on 7 of the 11 factors compared between the two stocks.

How does Aethlon Medical compare to SurgePays?

Aethlon Medical (NASDAQ:AEMD) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

In the previous week, Aethlon Medical had 1 more articles in the media than SurgePays. MarketBeat recorded 3 mentions for Aethlon Medical and 2 mentions for SurgePays. SurgePays' average media sentiment score of 1.15 beat Aethlon Medical's score of 0.98 indicating that SurgePays is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SurgePays	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 6.9% of SurgePays shares are owned by institutional investors. 0.7% of Aethlon Medical shares are owned by company insiders. Comparatively, 29.1% of SurgePays shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Aethlon Medical has higher earnings, but lower revenue than SurgePays. SurgePays is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A
SurgePays	$62.37M	0.16	-$36.07M	-$1.94	N/A

Aethlon Medical has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market. Comparatively, SurgePays has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market.

Aethlon Medical has a net margin of 0.00% compared to SurgePays' net margin of -64.91%. Aethlon Medical's return on equity of -137.73% beat SurgePays' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-137.73%	-105.87%
SurgePays	-64.91%	-967.32%	-310.16%

SurgePays has a consensus price target of $3.50, suggesting a potential upside of 782.50%. Given SurgePays' stronger consensus rating and higher possible upside, analysts plainly believe SurgePays is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
SurgePays	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

SurgePays beats Aethlon Medical on 8 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Sintx Technologies?

Aethlon Medical (NASDAQ:AEMD) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

Sintx Technologies has a consensus price target of $9.33, indicating a potential upside of 386.11%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Aethlon Medical has higher earnings, but lower revenue than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A
Sintx Technologies	$1.02M	8.13	-$10.36M	-$5.07	N/A

2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 0.7% of Aethlon Medical shares are owned by company insiders. Comparatively, 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Aethlon Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,058.60%. Aethlon Medical's return on equity of -137.73% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-137.73%	-105.87%
Sintx Technologies	-1,058.60%	-366.49%	-115.04%

In the previous week, Aethlon Medical had 2 more articles in the media than Sintx Technologies. MarketBeat recorded 3 mentions for Aethlon Medical and 1 mentions for Sintx Technologies. Aethlon Medical's average media sentiment score of 0.98 beat Sintx Technologies' score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aethlon Medical has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market. Comparatively, Sintx Technologies has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market.

Summary

Aethlon Medical beats Sintx Technologies on 8 of the 15 factors compared between the two stocks.

Get Aethlon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AEMD vs. The Competition

Export

Metric	Aethlon Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.27M	$53.12B	$6.45B	$12.38B
Dividend Yield	N/A	1.75%	2.69%	5.83%
P/E Ratio	-0.09	24.35	24.66	23.99
Price / Sales	N/A	0.65	526.33	107.23
Price / Cash	N/A	24.26	44.82	54.51
Price / Book	0.44	2.82	10.72	6.50
Net Income	-$7.15M	$1.46B	$3.56B	$336.88M
7 Day Performance	-28.80%	-2.47%	0.94%	-0.16%
1 Month Performance	-38.18%	-0.11%	0.36%	0.76%
1 Year Performance	-91.60%	-5.19%	29.67%	28.49%

Aethlon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AEMD Aethlon Medical	1.0811 of 5 stars	$1.36 -1.4%	N/A	-90.3%	$3.27M	N/A	N/A	10
ICU SeaStar Medical	2.2809 of 5 stars	$3.04 -2.9%	$8.00 +163.2%	+3.6%	$12.51M	$1.23M	N/A	2	News Coverage
FEMY Femasys	1.5023 of 5 stars	$3.84 -3.5%	$106.67 +2,677.8%	-77.7%	$12.02M	$2.29M	N/A	30
MBAI Check-Cap	0.4242 of 5 stars	$1.36 -5.6%	N/A	N/A	$10.49M	N/A	N/A	80	Positive News
SURG SurgePays	3.6542 of 5 stars	$0.44 +7.3%	$3.50 +695.5%	-85.5%	$10.30M	$56.96M	N/A	40	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AEMD) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aethlon Medical (AEMD) Competitors

AEMD vs. ICU, FEMY, MBAI, SURG, and SINT

How does Aethlon Medical compare to SeaStar Medical?

Summary

How does Aethlon Medical compare to Femasys?

Summary

How does Aethlon Medical compare to Check-Cap?

Summary

How does Aethlon Medical compare to SurgePays?

Summary

How does Aethlon Medical compare to Sintx Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aethlon Medical (AEMD) Competitors

AEMD vs. ICU, FEMY, MBAI, SURG, and SINT

How does Aethlon Medical compare to SeaStar Medical?

Is ICU or AEMD more profitable?

Which has more volatility and risk, ICU or AEMD?

Does the media favor ICU or AEMD?

Do insiders & institutionals have more ownership in ICU or AEMD?

Do analysts recommend ICU or AEMD?

Which has higher valuation & earnings, ICU or AEMD?

Summary

How does Aethlon Medical compare to Femasys?

Is FEMY or AEMD more profitable?

Does the media favor FEMY or AEMD?

Which has preferable earnings & valuation, FEMY or AEMD?

Do analysts recommend FEMY or AEMD?

Which has more volatility & risk, FEMY or AEMD?

Do insiders and institutionals believe in FEMY or AEMD?

Summary

How does Aethlon Medical compare to Check-Cap?

Is MBAI or AEMD more profitable?

Do analysts rate MBAI or AEMD?

Does the media favor MBAI or AEMD?

Which has more risk and volatility, MBAI or AEMD?

Which has better earnings & valuation, MBAI or AEMD?

Do institutionals and insiders hold more shares of MBAI or AEMD?

Summary

How does Aethlon Medical compare to SurgePays?

Does the media refer more to AEMD or SURG?

Do institutionals & insiders hold more shares of AEMD or SURG?

Which has stronger valuation & earnings, AEMD or SURG?

Which has more risk & volatility, AEMD or SURG?

Is AEMD or SURG more profitable?

Do analysts rate AEMD or SURG?

Summary

How does Aethlon Medical compare to Sintx Technologies?

Do analysts recommend AEMD or SINT?

Which has stronger earnings & valuation, AEMD or SINT?

Do insiders and institutionals believe in AEMD or SINT?

Is AEMD or SINT more profitable?

Does the media favor AEMD or SINT?

Which has more risk and volatility, AEMD or SINT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools